Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis

202220 citationsJournal Article

Authors

Andreas A. Argyriou · General University Hospital of Patras

George S. Vlachos · Hospital HLA Mediterráneo

Michail Vikelis · National and Kapodistrian University of Athens

Abstract

Considerably high adherence, considerable satisfaction and sustained safety/efficacy were observed in patients followed up for five years, supporting a favorable benefit/risk profile for consistently delivering long-term BoNTA in CM.

Topics & Keywords

Migraine and Headache Studies Cardiovascular Syncope and Autonomic Disorders Trigeminal Neuralgia and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Acta Neurologica Scandinavica

Volume 145, Issue 6, pp. 676-683

DOI: 10.1111/ane.13600

Field-Weighted Citation Impact: 2.83